Clear Street’s Starling Oncology Warrant STLNW Stock Holding History

Clear Street’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246	Sell	6,028 -200	-3%	-$10	﹤0.01%	1342
2026 Q1	$273	Buy	6,228 +200	+3%	+$19	﹤0.01%	1067
2025 Q4	$726	Sell	6,028 -100	-2%	-$16	﹤0.01%	878
2025 Q3	$735	Hold	6,128	–	–	﹤0.01%	782
2025 Q2	$314	Sell	6,128 -500	-8%	-$32	﹤0.01%	631
2025 Q1	$180	Buy	6,628 +5,000	+307%	+$130	﹤0.01%	530
2024 Q4	$8	Sell	1,628 -265	-14%	-$4	﹤0.01%	575
2024 Q3	$38	Sell	1,893 -500	-21%	-$10	﹤0.01%	675
2024 Q2	$63	Buy	2,393 +800	+50%	+$62	﹤0.01%	748
2024 Q1	$319	Hold	1,593	–	–	﹤0.01%	702
2023 Q4	$319	Buy	1,593 +500	+46%	+$79	﹤0.01%	717
2023 Q3	$100	Buy	1,093 +700	+178%	+$57	﹤0.01%	1027
2023 Q2	$11	Buy	393 +200	+104%	+$11	﹤0.01%	1278
2023 Q1	$13	Buy	+193	New	+$24	﹤0.01%	1155

Other funds holding STLNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AGM

Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Clear Street's STLNW Position: Q2 2026 in Review

Clear Street reduced its Starling Oncology Warrant (STLNW) stake by 3.2% in Q2 2026, selling an estimated $10 and leaving 6,028 shares worth $246. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Clear Street first reported a position in STLNW in Q1 2023 and has held it in 14 quarters since. The position peaked at $735 in Q3 2025. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.

Clear Street held 6,028 shares of Starling Oncology Warrant worth $246 as of Q2 2026.
Clear Street sold 200 Starling Oncology Warrant shares in Q2 2026, an estimated $10.
Starling Oncology Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1342 holding.
Clear Street first reported a position in Starling Oncology Warrant in Q1 2023 and has held it in 14 quarters since.
Clear Street's Starling Oncology Warrant position peaked at $735 in Q3 2025.
12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.